FIGURE

Figure 3

ID
ZDB-FIG-210902-174
Publication
Tavares Barroso et al., 2021 - Establishment of Pancreatobiliary Cancer Zebrafish Avatars for Chemotherapy Screening
Other Figures
All Figure Page
Back to All Figure Page
Figure 3

Zebrafish xenografts reveal sensitivity to the major therapeutic options for pancreatic cancer— FOLFIRINOX and gemcitabine plus paclitaxel chemotherapy. At 2 dpf, zebrafish embryos were injected with fluorescently labeled Panc-1 cells in the PVS. At 1 dpi, successfully injected xenografts were submitted to FOLFIRINOX or gem + paclitaxel treatment for three consecutive days and compared to control nontreated xenografts. At 4 dpi, zebrafish xenografts were imaged by confocal microscopy (ac). Maximum Z projections of activated caspase-3 (a’c’). Cell proliferation (% of mitotic figures), apoptotic index (% of activated caspase-3 in green), and tumor size (number of tumor cells, DAPI in blue) were analyzed and quantified (df, respectively). Data are shown as mean ± SEM. Statistical analysis was performed using Mann–Whitney test. Statistical results: (ns) > 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. The number of zebrafish xenografts analyzed is indicated in the figure. Results are from 3 independent experiments. Scale bars represent 50 µm. All images are anterior to the left, posterior to right, dorsal up, and ventral down.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells